Slate Path Capital LP - Q1 2016 holdings

$1.29 Billion is the total value of Slate Path Capital LP's 10 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 57.1% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRcall$328,832,0001,600,000
+100.0%
25.53%
GDX BuyMARKET VECTORS ETF TRgold miner etf$207,488,000
+142.4%
10,390,000
+66.5%
16.11%
+73.9%
PYPL BuyPAYPAL HLDGS INC$206,317,000
+20.6%
5,345,000
+13.1%
16.02%
-13.4%
CHTR BuyCHARTER COMMUNICATIONS INC Dcl a new$152,835,000
+21.0%
755,000
+9.4%
11.87%
-13.2%
TRIP BuyTRIPADVISOR INC$104,738,000
+22.6%
1,575,000
+57.1%
8.13%
-12.0%
PODD  INSULET CORP$90,195,000
-12.3%
2,720,0000.0%7.00%
-37.1%
TSO  TESORO CORP$85,580,000
-18.4%
995,0000.0%6.64%
-41.4%
ALNY BuyALNYLAM PHARMACEUTICALS INC$71,244,000
+4.4%
1,135,000
+56.6%
5.53%
-25.1%
TWC SellTIME WARNER CABLE INC$22,508,000
-34.4%
110,000
-40.5%
1.75%
-52.9%
OPHT NewOPHTHOTECH CORP$18,176,000430,000
+100.0%
1.41%
KMI ExitKINDER MORGAN INC DEL$0-1,030,000
-100.0%
-1.66%
CPGX ExitCOLUMBIA PIPELINE GROUP INC$0-805,000
-100.0%
-1.74%
WMB ExitWILLIAMS COS INC DEL$0-660,000
-100.0%
-1.84%
OKE ExitONEOK INC NEW$0-805,000
-100.0%
-2.15%
MDCO ExitMEDICINES CO$0-570,000
-100.0%
-2.30%
Z ExitZILLOW GROUP INCcl c cap stk$0-2,385,000
-100.0%
-6.06%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings